SESSION VII: CHRONIC LYMPHOCYTIC LEUKEMIA

Session Chairs: John Seymour, MBBS, FRACP, PhD and Lindsay Roeker, MD

Data From NGS What to Do With Additional Abnormalities Found at Diagnosis | Lydia Scarfò, MD | Università Vita-Salute San Raffaele, Milan, Italy

Optimizing Treatment Outcomes With Combination Therapies, Optimal Sequencing, and MRD-Guided Treatment Duration | Paula Cramer, MD | University of Cologne, Cologne, Germany

Debate: Debate: Progression on cBTKI: Change to Non-Covalent BTKi | Jeff P. Sharman, MD | Willamette Valley Cancer Institute-Sarah Cannon, Eugene, Oregon, USA

Debate: Progression on cBTKi: Change to Ven-Based Therapy | Gianluca Gaidano, MD, PhD | Amedeo Avogadro University of Eastern Piedmont, Novara, Italy

Interesting Clinical Case(s) | Mazyar Shadman, MD, MPH | Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

New Targets/Drugs on the Horizon | Meghan C. Thompson, MD | Memorial Sloan Kettering Cancer Center, New York, New York, USA

Oral Abstract TBA | Speaker | Affiliation, City, State, Country